There might be no better time to invest in biotech stocks.
This industry is receiving a ton of attention now, from both government and media.
Everyone is taking a closer look at drug prices.
We've been paying attention, too, and we know of a couple stocks that are ready to jump.
We're going to share with you the top two biotech stocks to buy now...
Investing in biotech stocks can be a dicey proposition in the current environment. It's a volatile industry to invest in, but the gains can be spectacular.
Thankfully the Money Morning Stock VQScore™ system can take the risk out of the equation.
Our proprietary stock picking system analyzes thousands of stocks every single day and shows us the picks that are priced for maximized returns.
And this week, three biotech stocks earned our highest score
Biotech firms offer extraordinary growth potential thanks to their development of new drugs.
If a drug wins FDA approval, the company's stock has the chance to rocket higher.
That's why we're bringing you the best biotech stocks to buy in September 2018...
The numbers are staggering. Over the next six years, the biotech market is expected to add an additional $593 billion in value – a 419% increase over the size of today's biotech market.
Growth like this is why Wall Street is rushing hand over foot to buy the most lucrative biotech stocks available. With thousands of biotech stocks on the market, identifying the best biotech stocks to buy is incredibly difficult.
